(Q42168613)

17 October 2017

Trafficking of NMDA receptors during status epilepticus: therapeutic implications (English)

1 reference

17 October 2017

1 reference

Claude G Wasterlain

1

1 reference

17 October 2017

David E Naylor

2

1 reference

17 October 2017

Hantao Liu

3

1 reference

17 October 2017

Jerome Niquet

4

1 reference

17 October 2017

Roger Baldwin

5

1 reference

17 October 2017

1 September 2013

1 reference

17 October 2017

1 reference

17 October 2017

54 Suppl 6

1 reference

17 October 2017

78-80

1 reference

Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus

17 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4551407

Intramuscular versus intravenous therapy for prehospital status epilepticus

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4551407

Rational polytherapy in the treatment of acute seizures and status epilepticus

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4551407

Felbamate in experimental model of status epilepticus

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4551407

NMDA receptor antagonists and limbic status epilepticus: a comparison with standard anticonvulsants

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4551407

Self-sustaining status epilepticus: a condition maintained by potentiation of glutamate receptors and by plastic changes in substance P and other peptide neuromodulators

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4551407

Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4551407

N-methyl-D-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4551407

Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4551407

Neuroprotective effect of ketamine administered after status epilepticus onset.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4551407

Epileptogenesis after self-sustaining status epilepticus.

17 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FEPI.12285

Misplaced NMDA receptors in epileptogenesis contribute to excitotoxicity

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24001081

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/EPI.12285

1 reference

17 October 2017

1 reference

17 October 2017

PubMed publication ID

24001081

1 reference